N-Nitroso Amitriptyline EP Impurity C
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Nortriptyline is indicated for use in the treatment of depression (FDA-approved). It can also be used off-label for conditions such as chronic pain, diabetic neuropathy, myofascial pain, orofacial pain, and postherpetic neuralgia. Nortriptyline has also shown to be useful in patients trying to quit smoking. N-Nitroso Nortriptylin is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Nortriptyline is also known as N-Nitroso N-Desmethyl Amitriptyline & N-Nitroso Amitriptyline EP Impurity C . It is chemically represented as N-(3-(10,11-dihydro-5H-dibenzo[a,d].[7]annulen-5-ylidene)propyl)-Nmethylnitrous amide . Synchemia is the leading manufacturing and exporter of N-Nitroso Nortriptyline . We supply N-Nitroso Nortriptyline with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143589 |
| CAS No | 96724-44-6 |
| Mol.F. | C5H11N3O3 |
| Mol.Wt. | 161.2g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143590 |
| CAS No | NA |
| Mol.F. | C12H17N3O3 |
| Mol.Wt. | 251.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143591 |
| CAS No | NA |
| Mol.F. | C12H18N2O3 |
| Mol.Wt. | 238.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143592 |
| CAS No | NA |
| Mol.F. | C28H32N4O3 |
| Mol.Wt. | 472.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143593 |
| CAS No | NA |
| Mol.F. | C24H32N4O5 |
| Mol.Wt. | 456.5g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143594 |
| CAS No | NA |
| Mol.F. | C10H20N2O8 |
| Mol.Wt. | 296.3 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0143595 |
| CAS No | 854234-69-8 |
| Mol.F. | C13H12N2O |
| Mol.Wt. | 212.25 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143596 |
| CAS No | NA |
| Mol.F. | C5H11ClN2O |
| Mol.Wt. | 150.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143597 |
| CAS No | NA |
| Mol.F. | C5H12N2O2 |
| Mol.Wt. | 132.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143598 |
| CAS No | NA |
| Mol.F. | C20H18N6O3 |
| Mol.Wt. | 390.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143599 |
| CAS No | NA |
| Mol.F. | C21H36N2O3 |
| Mol.Wt. | 364.5g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143600 |
| CAS No | NA |
| Mol.F. | C13H16N6O3 |
| Mol.Wt. | 304.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143601 |
| CAS No | NA |
| Mol.F. | C18H28N2O6 |
| Mol.Wt. | 368.4 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143602 |
| CAS No | NA |
| Mol.F. | C11H18N4O6S3 |
| Mol.Wt. | 398.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143603 |
| CAS No | NA |
| Mol.F. | C8H7D6N3OS |
| Mol.Wt. | 205.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143604 |
| CAS No | NA |
| Mol.F. | C17H17D3N2O2 |
| Mol.Wt. | 287.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |